MolNFT v1 · #142738 · protein
Crystal structure of the zika virus NS3 helicase (apo form)
6ADW · Serine protease NS3: “Crystal structure of the zika virus NS3 helicase (apo form)”. X-ray diffraction, 1 ligand (SO4), 3 pockets (best druggability 0.81). MolNFT v1 #142738 on GenesisL1: 3D structure, binding sites and pockets in…
- PDB
- 6ADW
- Type
- protein
- Length
- 434 residues
- Chains
- 1
- Method
- x-ray diffraction
- Collection
- MolNFT v1 / PDB
- Contract
- 0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
- Owner
- 0x3396CDB397284571d12822B4ae1189a8E22AAAAA
- Molecule
- Serine protease NS3
- EC
- 3.4.21.91, 3.6.1.15, 3.6.4.13
- UniProt
- Q32ZE1
- Ligands
- SO4
- Pockets
- 3 · best druggability 0.81
Structure
x-ray diffraction · 1 distinct chain · 33% helix, 19% strand (DSSP).
| Chain | Molecule | Type | Residues | Secondary structure | UniProt |
|---|---|---|---|---|---|
| A | Serine protease NS3 (EC 3.4.21.91, 3.6.1.15, 3.6.4.13) | protein | 434 | 33% helix, 19% strand | Q32ZE1 |
Ligands and binding sites
- SO4 · Sulfate ion · ion · 3 copies · chains A
- EPE · 4-(2-hydroxyethyl)-1-piperazine ethanesulfonic acid · additive · chains A
Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.
Pockets
3 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.
| Volume (ų) | Druggability | Buriedness | Lining residues | Inside | |
|---|---|---|---|---|---|
| 1 | 996 | 0.81 | 0.82 | 94 | SO4 |
| 2 | 85 | 0.66 | 0.92 | 24 | EPE |
| 3 | 51 | 0.25 | 0.73 | 11 | empty |
Compared structures
- 6ADW · Crystal structure of the Zika virus NS3 helicase (apo form) · the same entry in another collection · chain A against A, TM-score 1.00
Analyse
- Open in the research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides and crosslinks on the 3D structure
- Every structure of UniProt Q32ZE1
- Elsewhere: RCSB PDB 6ADW · PDBe 6ADW · UniProt Q32ZE1
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.